Mir-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 28019-28039

  Kim, Youngmi ^a   Kim, Hyuna ^a   Park, Hyunmi ^a   Park, Deokbum ^a   Lee, Hansoo ^a   Lee, Yun Sil ^b   Choe, Jongseon ^a   Kim, Young Myeong ^a   Jeoung, Dooil ^a  

^a Kangwon National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER DRUG; FEED-BACK LOOP;

ANTINEOPLASTIC AGENT; CASPASE 3; CELASTROL; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; MICRORNA; MICRORNA 200B; MICRORNA 217; MICRORNA 326; MICRORNA 335; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE; MIRN326 MICRORNA, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CARCINOGENESIS; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; METASTASIS POTENTIAL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TUMOR INVASION; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOGENESIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84907495054     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.578229     Document Type: Article

References (49)

1. Jin, W., Liu, Y., Xu, S. G., Yin, W. J, Li, J.J., Yang, J. M., and Shao, Z. M. (2010) UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. Breast Cancer Res. Treat. 124, 39-48
2. To, K. K., Polgar, O., Huff, L. M., Morisaki, K., and Bates, S. E. (2008) Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multi drug-resistant cells. Mol. Cancer Res. 6,151-164
3. Mahlknecht, U., Emiliani, S., Najfeld, V., Young, S., and Verdin, E. (1999) Genomic organization and chromosomal localization of the human his-tone deacetylase 3 gene. Genomics 56,197-202
4. Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J, and Wong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350
5. Zhang, J., Kalkum, M., Chait, B. T., and Roeder, R. G. (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611-623
6. Chen, L. F., Fischle, W., Verdin, E., and Greene, W. C. (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653-1657
7. Mahlknecht, U., Will, J., Varin, A., Hoelzer, D., and Herbein, G. (2004) Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression.J. Immunol. 173, 3979-3990
8. Bardai, F. H., and D'Mello, S. R. (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3β3.J. Neurosci. 31,1746-1751
9. Uo, T., Veenstra, T. D., and Morrison, R. S. (2009) Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J. Neurosci. 29, 2824-2832
10. Kim, H. C, Choi, K. C, Choi, H. K., Kang, H. B., Kim, M. J., Lee, Y. H., Lee, O. H., Lee, J., Kim, Y. J., Jun, W., Jeong, J. W., and Yoon, H. G. (2010) HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell. Mol. Life Sci. 67, 3499 -3510
11. Ott, P. A., Chang, J., Madden, K., Kann an, R., Muren, C., Escano, C., Cheng, X., Shao, Y., Mendoza, S., Gandhi, A., Liebes, L., and Pavlick, A. C. (2013) Oblimersen in combination with temozolomide and albuminbound paclitaxel in patients with advanced melanoma: a phase I trial. Cancer Chemother. Pharmacol. 71,183-191
12. Chae, S., Kim, Y. B., Lee, J. S., and Cho, H. (2012) Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis. Am.J Physiol. Gastrointest. Liver Physiol. 302, G1016-G1024
13. Xu, R., Nakano, K., Iwasaki, H., Kumagai, M., Wakabayashi, R., Yamasaki, A., Suzuki, H., Mibu, R., Onishi, H., and Katano, M. (2011) Dual blockade of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer. Cancer Lett. 306,151-160
14. Xu, R., Sato, N., Yanal, K., Akiyoshi, T., Nagai, S., Wada, J., Koga, K., Mibu, R., Nakamura, M., and Katano, M. (2009) Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase path-way in colon cancer cells. Anticancer Res. 29, 261-270
15. Calin, G. A., and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866
16. Cheng, W., Liu, T., Wan, X., Gao, Y., and Wang, H. (2012) MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J. 279, 2047-2059
17. Chen, Z., Ma, T., Huang, C., Zhang, L., Lv, X., Xu, T., Hu, T., and Li, J. (2013) miR-27a modulates the MDRl/P-glycoprotein expression by in-hibiting FZD7/β;-catenin pathway in hepatocellular carcinoma cells. Cell. Signal. 25, 2693-2701
18. Kim, Y., Park, D., Kim, H., Choi, M., Lee, H., Lee, Y. S., Choe, J., Kim, Y. M., and Jeoung, D. (2013) miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. J. Biol.Chem. 288,36502-36518
19. Fabbri, M., Garzon, R, Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., Volinia, S., Guler, G., Morrison, C. D., Chan, K. K., Marcucci, G., Calin, G. A., Huebner, K., and Croce, C. M. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104,15805-15810
20. Zhao, J. J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., Dessureault, S., Moscinski, L. C., Rezania, D., Dalton, W. S., Sotomayor, E., Tao, J., and Cheng, J. Q. (2010) microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 115, 2630 -2639
21. Yang, H., Chen, D., Cui;, Q. C., Yuan, X., and Dou, Q. P. (2006) Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 66, 4758-4765
22. Kannaiyan, R., Manu, K. A., Chen, L., Li, F., Rajendran, P., Subramaniam, A., Lam, P., Kumar, A. P., and Sethi, G. (2011) Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 16,1028-1041
23. Williams, L. V., Veliceasa, D., Vinokour, E., and Volpert, O. V. (2013) miR-200b inhibits prostate cancer EMT, growth and metastasis. PLoS One 8,e83991
24. Hummel, R., Hussey, D. J., and Haler, J. (2010) MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer 46, 298-311
25. Wang, H., Li, M., Zhang, R., Wang, Y., Zang, W., Ma, Y., Zhao, G., and Zhang, G. (2013) Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 andH1299. Tumour Biol. 34,3101-3109
26. Zhao, W. G., Yu, S. N., Lu, Z. H., Ma, Y. H., Gu, Y. M., and Chen,J. (2010) The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726-1733
27. Scott, G. K., Mattie, M. D., Berger, C. E., Benz, S. C., and Benz, C. C. (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 66,1277-1281
28. Zhang, X., Zhao, X., Fiskus, W., Lin, J., Lwin, T., Rao, R., Zhang, Y., Chan, J. C, Fu, K., Marquez, V. E., Chen-Kiang, S., Moscinski, L. C, Seto, E., Dalton, W. S., Wright, K. L., Sotomayor, E., Bhalla, K., and Tao, J. (2012) Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell 22, 506 -523
29. Suzuki, H. I, Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., and Miyazono, K. (2009) Modulation of microRNA processing by p53 .Nature 460,529-533
30. Zhang, X., Wan, G., Berger, F. G., He, X., and Lu, X. (2011) The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41, 371-383
31. Scarola, M., Schoeftner, S., Schneider, C., and Benetti, R. (2010) miR-335 directly targets Rbl (pRb/pl05) in a proximal connection to p53-dependent stress response. Cancer Res. 70, 6925-6933
32. Tan, Z., Jiang, H., Wu, Y., Xie, L., Dai, W., Tang, H., and Tang, S. (2014) miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol. Cell. Biochem. 386, 223-231
33. Por, E., Byun, H. J., Lee, E. J., Lim, J. H., Jung, S. Y., Park, I, Kim, Y. M., Jeoung, D. L, and Lee, H. (2010) The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins DI and E in an API- and E2F-dependent manner. J. Biol. Chem. 285, 14475-14485
34. Kim, Y., Park, H., Park, D., Lee, Y. S., Choe, J., Hahn, J. H., Lee, H., Kim, Y. M., and Jeoung, D. (2010) Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.J. Biol. Chem. 285, 25957-25968
35. Park, D., Park, H., Kim, Y., Kim, H., and Jeoung, D. (2014) HDAC3 acts as a negative regulator of angiogenesis. BMB Rep. 47, 227-232
36. El-Khoury, V., Breuzard, G., Fourré, N., and Dufer, J. (2007) The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. Br. J. Cancer 97, 562-573
37. Aghdassi, A., Sendler, M., Guenther, A., Mayerle, J., Behn, C. O., Heidecke, C. D., Friess, H., Büchler, M., Evert, M., Lerch, M. M., and Weiss, F. U. (2012) Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Gut 61, 439-448
38. Liu, Z., Liu, H., Desai, S., Schmitt, D. C., Zhou, M., Khong, H. T., Klos, K.S., McClellan, S., Fodstad, O., and Tan, M. (2013) miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.J. Biol. Chem. 288, 4334-4345
39. Noh, J. H., Chang, Y. G., Kim, M. G., Jung, K. H., Kim, J. K., Bae, H. J., Eun, J. W., Shen, Q., Kim, S. J., Kwon, S. H., Park, W. S., Lee, J. Y., and Nam, S. W. (2013) MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett. 335, 455-462
40. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., and Abeliovich, A. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317,1220-1224
41. Bar, N., and Dikstein, R. (2010) miR-22 forms a regulatory loop in PTEN/ AKT pathway and modulates signaling kinetics. PLoS One 5, e10859
42. Liu, C., Teng, Z. Q., McQuate, A. L., Jobe, E. M., Christ, C. C., von Hoyningen-Huene, S. J., Reyes, M. D., Polich, E. D., Xing, Y., Li, Y., Guo, W., and Zhao, X. (2013) An epigenetic feedback regulatory loop involving microRNA-195 and MBD1 governs neural stem cell differentiation. PLoS One 8, e51436
43. Li, Y., Gao, L., Luo, X., Wang, L, Gao, X., Wang, W., Sun, J., Dou, L, Li, J., Xu, C., Wang, L., Zhou, M., Jiang, M., Zhou, J., Caligiuri, M. A., Nervi, C., Bloomfield, C. D., Marcucci, G., and Yu, L. (2013) Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood 121, 499-509
44. Zhou, J., Xu, T., Yan, Y., Qin, R, Wang, H., Zhang, X., Huang, Y., Wang, Y., Lu, Y., Fu, D., and Chen, J. (2013) MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1). PLoS One 8, e68469
45. Liang, Z., Wu, H., Xia, J., Li, Y., Zhang, Y., Huang, K., Wagar, N., Yoon, Y., Cho, H. T., Scala, S., and Shim, H. (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem. Pharmacol. 79, 817-824
46. Kefas, B., Comeau, L., Floyd, D. H., Seleverstov, O., Godlewski, J., Schmittgen, T., Jiang, J., diPierro, C. G., Li, Y., Chiocca, E. A., Lee, J., Fine, H., Abounader, R., Lawler, S., and Purow, B. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.J. Neurosci. 29, 15161-15168
47. Li, Y., Zhang, J., Zhang, L., Si, M., Yin, H., and Li, J. (2013) Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis 34,1601-1610
48. Sankar, N., Baluchamy, S., Kadeppagari, R. K., Singhal, G., Weitzman, S., and Thimmapaya, B. (2008) p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27, 5717-5728
49. Bitarte, N., Bandres, E., Boni, V., Zarate, R., Rodriguez, J., Gonzalez-Hua-rriz, M., Lopez, L, Javier Sola, J., Alonso, M. M., Fortes, P., and Garcia-Foncillas, J. (2011) MicroRNA-451 is involved in the self-renewal, tumor -igenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29,1661-1671